Helen C. Adams
CIK: 0001488486
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMMX
Immix Biopharma, Inc.
Director
Discretionary Trading P&L
Holdings
About Adams Helen C.
Adams Helen C. (SEC CIK 0001488486) files insider reports with the SEC as Director of Immix Biopharma, Inc. (IMMX).
Signal8 holds 2 ownership filings by Adams Helen C., all Form 4s, filed between Jun 23, 2025 and May 29, 2026. Those filings report 2 transactions, from Jun 20, 2025 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Adams Helen C.'s filings is in LOS ANGELES, CA.
Recent filings by Adams Helen C.
Other insiders filing for Immix Biopharma, Inc. (IMMX)
- Ng Carey, Director
- Marquet Magda, Director
- Morris Gabriel S, CFO, President
- CHANG NANCY T, Director
- Rachman Ilya M, CEO and Chairman
- Chudnovsky Yekaterina, Director